These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21030198)

  • 1. Treatment of peripheral arterial disease using stem and progenitor cell therapy.
    Lawall H; Bramlage P; Amann B
    J Vasc Surg; 2011 Feb; 53(2):445-53. PubMed ID: 21030198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal.
    Lawall H; Bramlage P; Amann B
    Thromb Haemost; 2010 Apr; 103(4):696-709. PubMed ID: 20174766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.
    Matoba S; Tatsumi T; Murohara T; Imaizumi T; Katsuda Y; Ito M; Saito Y; Uemura S; Suzuki H; Fukumoto S; Yamamoto Y; Onodera R; Teramukai S; Fukushima M; Matsubara H;
    Am Heart J; 2008 Nov; 156(5):1010-8. PubMed ID: 19061721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous bone marrow cell therapy for patients with peripheral arterial disease: a meta-analysis of randomized controlled trials.
    Wen Y; Meng L; Gao Q
    Expert Opin Biol Ther; 2011 Dec; 11(12):1581-9. PubMed ID: 21973046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia.
    Wang SK; Green LA; Motaganahalli RL; Wilson MG; Fajardo A; Murphy MP
    J Vasc Surg; 2017 Jun; 65(6):1850-1857.e2. PubMed ID: 28390770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
    Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR
    J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia.
    Iafrati MD; Hallett JW; Geils G; Pearl G; Lumsden A; Peden E; Bandyk D; Vijayaraghava KS; Radhakrishnan R; Ascher E; Hingorani A; Roddy S
    J Vasc Surg; 2011 Dec; 54(6):1650-8. PubMed ID: 22019148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety and Therapeutic Efficacy of Angiogenesis Induced by Intraarterial Autologous Bone Marrow-Derived Stem Cells in Patients with Severe Peripheral Arterial Disease.
    Sharma S; Pandey NN; Sinha M; Kumar S; Jagia P; Gulati GS; Gond K; Mohanty S; Bhargava B
    J Vasc Interv Radiol; 2021 Feb; 32(2):157-163. PubMed ID: 33248918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment.
    Sprengers RW; Teraa M; Moll FL; de Wit GA; van der Graaf Y; Verhaar MC; ;
    J Vasc Surg; 2010 Oct; 52(4):843-9, 849.e1. PubMed ID: 20598482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia.
    Perin EC; Silva G; Gahremanpour A; Canales J; Zheng Y; Cabreira-Hansen MG; Mendelsohn F; Chronos N; Haley R; Willerson JT; Annex BH
    Catheter Cardiovasc Interv; 2011 Dec; 78(7):1060-7. PubMed ID: 21594960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia.
    Ruiz-Salmeron R; de la Cuesta-Diaz A; Constantino-Bermejo M; Pérez-Camacho I; Marcos-Sánchez F; Hmadcha A; Soria B
    Cell Transplant; 2011; 20(10):1629-39. PubMed ID: 22289660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autologous bone marrow stem cell or peripheral blood endothelial progenitor cell therapy in patients with peripheral limb ischaemia].
    Boda Z; Veréb Z; Rajnavölgyi E
    Orv Hetil; 2006 Jun; 147(25):1155-60. PubMed ID: 16893130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters.
    Malyar NM; Radtke S; Malyar K; Arjumand J; Horn PA; Kröger K; Freisinger E; Reinecke H; Giebel B; Brock FE
    Cytotherapy; 2014 Sep; 16(9):1270-9. PubMed ID: 24972744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell therapy in peripheral arterial disease.
    Al Mheid I; Quyyumi AA
    Angiology; 2008 Dec-2009 Jan; 59(6):705-16. PubMed ID: 18818233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limb salvage using intramuscular injection of unfractionated autologous bone marrow mononuclear cells in critical limb ischemia: a prospective pilot clinical trial.
    Gabr H; Hedayet A; Imam U; Nasser M
    Exp Clin Transplant; 2011 Jun; 9(3):197-202. PubMed ID: 21649569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of peripheral arterial disease and its relevance to the diabetic population.
    Faglia E
    Int J Low Extrem Wounds; 2011 Sep; 10(3):152-66. PubMed ID: 21856972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic angiogenesis by stem cell transplantation].
    Shioyama W; Komuro I
    Nihon Rinsho; 2011 Dec; 69(12):2241-5. PubMed ID: 22242327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA).
    Walter DH; Krankenberg H; Balzer JO; Kalka C; Baumgartner I; Schlüter M; Tonn T; Seeger F; Dimmeler S; Lindhoff-Last E; Zeiher AM;
    Circ Cardiovasc Interv; 2011 Feb; 4(1):26-37. PubMed ID: 21205939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.
    Kawamoto A; Katayama M; Handa N; Kinoshita M; Takano H; Horii M; Sadamoto K; Yokoyama A; Yamanaka T; Onodera R; Kuroda A; Baba R; Kaneko Y; Tsukie T; Kurimoto Y; Okada Y; Kihara Y; Morioka S; Fukushima M; Asahara T
    Stem Cells; 2009 Nov; 27(11):2857-64. PubMed ID: 19711453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.